Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia.
about
Endometrial shedding effect on conception and live birth in women with polycystic ovary syndromeDirect effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma.Characterization of GAB1 expression over the menstrual cycle in women with and without polycystic ovarian syndrome provides a new insight into its pathophysiologyObesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation.Assessing and treating insulin resistance in women with polycystic ovarian syndromeRNA-Seq analysis of yak ovary: improving yak gene structure information and mining reproduction-related genes.Reversing the reduced level of endometrial GLUT4 expression in polycystic ovary syndrome: a mechanistic study of metformin action.Protein expression of PKCZ (Protein Kinase C Zeta), Munc18c, and Syntaxin-4 in the insulin pathway in endometria of patients with polycystic ovary syndrome (PCOS)Lack of cyclical fluctuations of endometrial GLUT4 expression in women with polycystic ovary syndrome: Evidence for direct regulation of GLUT4 by steroid hormones.Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus.Glucose transporters in the uterus: an analysis of tissue distribution and proposed physiological roles.Endometrial signaling pathways during ovarian stimulation for assisted reproduction technology.Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.Current perspectives of insulin resistance and polycystic ovary syndrome.Endometrial abnormality in women with polycystic ovary syndrome.Hyperandrogenism Decreases GRP78 Protein Level and Glucose Uptake in Human Endometrial Stromal Cells.Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome.Insulin receptor and glucose transporters mRNA expression throughout the menstrual cycle in human endometrium: a physiological and cyclical condition of tissue insulin resistance.Effect of TNF-α on Molecules Related to the Insulin Action in Endometrial Cells Exposed to Hyperandrogenic and Hyperinsulinic Conditions Characteristics of Polycystic Ovary Syndrome.Evidence for decreased expression of APPL1 associated with reduced insulin and adiponectin receptors expression in PCOS patients.
P2860
Q33555348-AE4B8618-2766-4F02-AEB7-50A543E3DCF6Q33675285-9A739845-3DD5-4D4A-A0B7-820561FFDD82Q34468127-21D61CB8-F778-4825-8D29-7CFB07907DADQ34766224-F78512F0-D8D7-4A35-B9B5-2F3421DE0F4EQ34878055-07541A08-FB95-46EE-8CDC-6E186D835249Q35183433-6DEDC549-401B-4BC4-B25B-3868F79F3EFBQ35662997-5FB4D5FE-0770-488D-A0DC-EBE10D058587Q35866268-85F3001F-7F99-44B7-9FE3-6651ECE11EC3Q36324375-95BF414E-5698-4D42-90C2-BC01F7669351Q37128592-3CF85077-2391-4816-B45A-3F5CC4184D82Q37265982-17A479A6-E6ED-4004-A2EF-02A774699675Q37433468-C51A8FF5-E880-49BA-B1FD-9A1F73641E0BQ37830746-BA91AC42-6DE6-49A8-A162-5CA3DA93025DQ37939291-75B08A9B-FA51-4B56-A6B9-98CF9D80A24CQ38005532-8CE0D8D5-40E1-422A-B7FB-4361996C9DCDQ38816150-6738FE43-AB97-46C0-8C26-1185214CBFD2Q38950805-C1D1B5D5-8345-44E5-A606-FBC6359007F9Q43655650-6A84B93F-3929-4D4F-91D2-20D345612D1BQ47745612-B475A16E-4568-4327-B931-8C536A42EC9AQ53122744-437C4A92-290F-4E00-8441-9027EDA1B4EE
P2860
Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Changes in the expression of i ...... h or without hyperinsulinemia.
@en
Changes in the expression of i ...... h or without hyperinsulinemia.
@nl
type
label
Changes in the expression of i ...... h or without hyperinsulinemia.
@en
Changes in the expression of i ...... h or without hyperinsulinemia.
@nl
prefLabel
Changes in the expression of i ...... h or without hyperinsulinemia.
@en
Changes in the expression of i ...... h or without hyperinsulinemia.
@nl
P2093
P2860
P1433
P1476
Changes in the expression of i ...... h or without hyperinsulinemia.
@en
P2093
Carlos Rosas
Carmen Romero
David Vantman
Fernando Gabler
Margarita Vega
Paulina Ormazabal
Romina Fornes
P2860
P2888
P304
P356
10.2119/MOLMED.2009.00118
P407
P577
2009-12-04T00:00:00Z
P5875
P6179
1068965223